(Last 5 years)

Proctor SD, Kelly S and Russell JC. A novel of arginine-silicate improves Micro- and Macrovascular Function and inhibits glomerular sclerosis in Insulin-Resistant JCR:LA-cp Rats. Diabetologia 2005. Apr; 48(9):1925-32. Epub 2005 Jul 1. (IF=5.7)

Russell JC, Proctor SD, Kelly SE, Löhn M, Busch AE and Schäfer S. Insulin-Sensitising and Cardiovascular Effects of the Sodium-Hydrogen Exchange Inhibitor, Cariporide, in the JCR:LA-cp Rat and db/db Mouse. Journal of Cardiovascular Pharmacology. 2005 Dec; 46(6):746-753. (IF=1.6)

Proctor SD, Dreher K.L, Kelly S.E and Russell JC. Hypersensitivity of Prediabetic JCR:LA-cp Rats to fine airborne Combustion particle-Induced Direct and Noradrenergic-Mediated Vascular Contraction. Toxicological Sciences 2006 Jan; 90(2):385-391. (IF=3.4)

Russell JC and Proctor SD Small animal models of cardiovascular disease: Tools for study of roles of the metabolic syndrome, dyslipidemias and atherosclerosis. Review for Cardiovascular Pathology 2006:15;318-330. (IF=1.7).

Vine DF, Takechi R, Russell JC and Proctor SD. Impaired postprandial apolipoprotein-B48 metabolism in obese insulin-resistant JCR:LA-cp rat: Increased atherogenicity for the metabolic syndrome. Atherosclerosis 2007 190(2):282-90. EPub.2006 Apr. (IF=3.8)

Proctor SD, Kelly SE, Stanhope KL, Havel PJ, and Russell JC. Synergistic effects of conjugated linoleic acid and chromium picolinate improve vascular function and renal pathophysiology in the insulin-resistant JCR:LA-cp rat. Diabetes, Obesity and Metabolism. 9,(1): 87-95 2007 (IF=2.5)

Russell JC and Proctor SD. Increased insulin sensitivity and reduced micro and macro vascular disease induced by 2-deoxy-D-glucose during metabolic syndrome in obese JCR:LA-cp rats. British Journal of Pharmacology 151(2):216-225 2007. Jan epub 20 March 2007 (IF=3.4).

Mangat R, J. Su, P.G. Scott, J.C. Russell, Vine DF and Proctor SD. Chylomicron and apoB48 metabolism in the JCR:LA corpulent rat, a model for the metabolic syndrome. Biochemical Society Transactions 2007 Jun; 35(Pt 3):477-81. (IF=3.1)

Nzekwu MMU, Jetha MM, Ball GDC, C.Beaulieu and Proctor SD. Apolipoprotein B48: a novel marker of metabolic risk in overweight children? Biochemical Society Transactions 2007 Jun; 35(Pt 3):484-6. (IF=3.1)

Pierce D, Heth D, Owczarczyk J, Russell JC and Proctor SD. Overeating by Young Obesity-prone and Lean Rats caused by tastes Associated with Low Energy Foods. Obesity (Silver Spring). 2007 Aug; 15(8):1969-79.

Proctor SD, Kelly S, Vine DF and Russell JC. Metabolic effects of a novel silicate inositol complex of the nitric oxide precursor arginine in the obese insulin- resistant JCR:LA-cp rat. Metabolism 2007 May; 56(10):1318-25.

Proctor SD Trans fats, dyslipidemia and the metabolic syndrome: are we missing the cream? Can Nurse. 2007 Nov; 103(9):10.

Duez H, Lamarche B, Valéro R, Pavlic M, Proctor SD, Xiao C, Szeto L, Patterson BW and Lewis GF. Both intestinal and hepatic lipoprotein production are stimulated by an acute elevation of plasma free fatty acids in humans. Circulation 2008 May 6; 117(18):2369-76. Epub 2008 Apr 28 (IF=11.2).

Russell JC, Proctor SD, Kelly SE and Brindley D. Pair feeding-mediated changes in metabolism: stress response and pathophysiology in insulin resistant, atherosclerosis-prone JCR:LA-cp rats. American Journal of Physiology: Endocrinology and Metabolism. 2008 April; 294(6):E1078-87.

Proctor SD, Vine DF, Botham K, Mamo JCL and Cabezas MC. Intestinal post-prandial chylomicrons: State of the Union between liver, gut and dyslipidemia? Future Lipidology 2008. 3(5), 473-480.

Vine DF, Glimm DR, Proctor SD. Intestinal Lipid Transport and Chylomicron Production: Possible Links to Exacerbated Atherogenesis in a Rodent Model of the Metabolic Syndrome. Atherosclerosis Supplements, 9(2008):69-76. Accepted 13 May 2008. (IF=4.287).

Wang Y, Lu J, Ruth MR, Goruk SD, Reaney M, Glimm D, Vine DF, Field CJ and Proctor SD (2008). Trans-11 vaccenic acid dietary supplementation induces hypolipidemic effects in an animal model of dyslipidemia and the metabolic syndrome. Journal of Nutrition. 138(11):2117-22. (IF=4.0).

Ruth MR, Proctor SD and Field CJ. Feeding long chain (n-3) polyunsaturated fatty acids to obese leptin receptor deficient JCR:LA-cp rats modifies immune function and lipid raft fatty acid composition. British Journal of Nutrition page 1 of 10. Accepted 20 Aug 2008. (IF=2.34).

Ruth MR, Proctor SD and Field CJ. Effect of Feeding Fish Oil on mesenteric lymph node cytokine responses in obese leptin receptor-deficient JCR:LA-cp Rats. International Journal of Obesity (2009) 33, 96-103. Acceptance 5 October 2008, published online 2 December 2008. (IF=3.56).

Su JW, Lambert JE, Clandinin MT and Proctor SD. Impaired Postprandial metabolism of Apolipoprotein B48-Containing Remnant Particles in Normolipidemic Subjects with Brittle Type 1 Diabetes. Diabetes Care Vol 32 (2), February 2009 DOI 10.2337/dc08-1573 (IF=7.8).

Blewett HJ, Gergung CA, Ruth MR, Proctor SD and Field CJ. Vaccenic acid favorably alters immune function in obese JCR:LA-cp rats. Br J. Nutr. 2009 Feb 16:1-11

Su JW, Nzekwu MMU, Ball GDC, Proctor SD. Postprandial lipemia as an early predictor of cardiovascular complications in childhood obesity. Journal of Clinical Lipidology. Accepted Feb 8 2009, Vol.3, 78-84.

Su JW, Nzekwu MMU, Castro-Cabezas M, Redgrave TG, Proctor SD. Methods to assess impaired post-prandial metabolism and the impact for early detection of cardiovascular disease risk. European Journal of Clinical Investigation. 2009 Sep;39(9):741-54. (IF=2.701).

Field CJ, Hosea-Blewett H, Proctor SD and Vine DF. Human health benefits of vaccenic acid. Applied Physiology, Nutrition and Metabolism. MS#08-214, Vol. 34, Number 5, 979-991, October 2009.

Shi D, Dyck MK, Uwiera RR, Russell JC, Proctor SD, Vine DF. A Unique Rodent Model of Cardiometabolic Risk Associated with the Metabolic Syndrome and Polycystic Ovary Syndrome. Endocrinology. Vol. 150, No. 9 4425-4436, May 2009. (IF=5.5)

Wang Y, Lu J, Ruth MR, Goruk SD, Reaney M, Glimm D, Vine DF, Field CJ and Proctor SD. Trans-11 vaccenic acid reduces hepatic lipogenesis and chylomicron secretion in the JCR:LA-cp rat. Journal of Nutrition. In press 2009. (IF=4.0)

Hassanali Z, Ametaj B, Field CJ, Proctor SD and Vine DF. Dietary Supplementation of n-3 PUFA reduces weight gain, and improves post-prandial lipemia and the associated inflammatory response in the obese JCR:LA-cp rat . Diabetes, Obesity and Metabolism. In press 2009. (IF=3.5)

Russell JC, Kelly SE, Vine DF and Proctor SD. Irbesartan-mediated reduction of renal and cardiac damage in insulin resistant JCR:LA-cp rats. British Journal of Pharmacology. In press 2009.